Zomedica Corp ZOM:NYSE American

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/03/24 EDT
0.14quote price arrow down-0.0005 (-0.3444%)
Volume
255,695
Close
0.1452quote price arrow up+0.0032 (+2.2535%)
Volume
8,303,046
52 week range
0.12 - 0.25
Loading...
  • Open0.142
  • Day High0.1489
  • Day Low0.1371
  • Prev Close0.142
  • 52 Week High0.25
  • 52 Week High Date07/12/23
  • 52 Week Low0.12
  • 52 Week Low Date02/16/24

Key Stats

  • Market Cap142.289M
  • Shares Out979.95M
  • 10 Day Average Volume4.53M
  • Dividend-
  • Dividend Yield-
  • Beta0.86
  • YTD % Change-27.47

KEY STATS

  • Open0.142
  • Day High0.1489
  • Day Low0.1371
  • Prev Close0.142
  • 52 Week High0.25
  • 52 Week High Date07/12/23
  • 52 Week Low0.12
  • 52 Week Low Date02/16/24
  • Market Cap142.289M
  • Shares Out979.95M
  • 10 Day Average Volume4.53M
  • Dividend-
  • Dividend Yield-
  • Beta0.86
  • YTD % Change-27.47

RATIOS/PROFITABILITY

  • EPS (TTM)-0.04
  • P/E (TTM)-4.12
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-25.293M
  • ROE (TTM)-13.61%
  • Revenue (TTM)25.186M
  • Gross Margin (TTM)68.76%
  • Net Margin (TTM)-137.10%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/09/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Zomedica Corp

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Zomedica Corp. is a veterinary health company. The Company is engaged in creating products for horses, dogs, and cats by focusing on the unmet needs of clinical veterinarians. The Company's product portfolio includes diagnostics and medical devices that emphasize patient health and practice health. Its Diagnostics segment consists of TRUFORMA, VetGuardian, and TRUVIEW products. Its Therapeutic Devices segment consists of Assisi and PulseVet products. Its TRUFORMA platform...
Jeffrey Rowe
Independent Chairman of the Board
Larry Heaton II
Chief Executive Officer
Anthony Blair
Chief Operating Officer
Peter Donato
Chief Financial Officer
Karen Dehaanfullerton
Chief Counsel, Company Secretary
Adrian Lock
Vice President, General Manager, Chief Executive Officer of Pulse Veterinary Technologies, LLC
Address
100 Phoenix Drive, Suite 125
Ann Arbor, MI
48108
United States

Top Peers

SYMBOLLASTCHG%CHG
MDNA
Medicenna Therapeutics Corp
2.39+0.01+0.42%
CRDL
Cardiol Therapeutics Inc
1.99+0.01+0.51%
SVA
Sinovac Biotech Ltd
0.00-6.47-100.00%
DMAC
DiaMedica Therapeutics Inc
3.00+0.37+14.07%
EPRX
Eupraxia Pharmaceuticals Inc
2.88+0.10+3.78%